Abstract
Background
Vitamin D is shown to be a potent immunomodulator. Considering the potential role of low serum vitamin D levels in autoimmune disorder, we evaluated the association between Hashimoto’s thyroiditis (HT) (with subclinical or overt hypothyroidism) and serum 25-hydroxyvitamin D (25OHD) levels in an Iranian population.
Methods
A total number of 86 individuals were enrolled. The case group included 41 patients with hypothyroid HT (overt or subclinical). The control group comprised 45 healthy euthyroid persons. Serum 25OHD levels were measured in all subjects.
Results
The case:control ratio of geometric means of 25OHD levels was 0.66 (95 % CI: 0.49–0.90; P = 0.008). There was a significant inverse association between serum 25OHD levels and HT (OR: 0.81 for 5 ng/ml increase in 25OHD level, 95 % CI: 0.68–0.96; P = 0.018). This association remained significant after adjustment for potential confounding factors including age, sex and BMI.
Conclusions
Our study suggested that higher serum 25OHD levels was associated with decreased risk of HT so that each 5 ng/ml increase in the serum 25OHD levels results in 19 % decrease in odds of HT.
Similar content being viewed by others
References
Muszkat P, Camargo MB, Griz LH, Lazaretti-Castro M (2010) Evidence-based non-skeletal actions of vitamin D. Arq Bras Endocrinol Metabol 54(2):110–117
Zügel U, Steinmeyer A, May E, Lehmann M, Asadullah K (2009) Immunomodulation by a novel, dissociated Vitamin D analogue. Exp Dermatol 18(7):619–627
Samuel S, Sitrin MD (2008) Vitamin D’s role in cell proliferation and differentiation. Nutr Rev 66:116–124
Dayan CM, Daniels GH (1996) Chronic autoimmune thyroiditis. N Engl J Med 335:99–107
Martin A, Davies TF (1992) T cells and human autoimmune thyroid disease: emerging data show lack of need to invoke suppressor T cell problems. Thyroid 2(3):247–261
Kamen DL, Cooper GS, Bouali H, Shaftman SR, Hollis BW, Gilkeson GS (2006) Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev 5(2):114–117
Carvalho JF, Blank M, Kiss E, Tarr T, Amital H, Shoenfeld Y (2007) Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 1109:550–557
Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296(23):2832–2838
van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, Kilpatrick T et al (2007) Vitamin D levels in people with multiple sclerosis and community controls in Tasmania. Aust J Neurol 254(5):581–590
Mathieu C, Gysemans C, Giulietti A, Bouillon R (2005) Vitamin D and diabetes. Diabetologia 48(7):1247–1257
Mohr SB, Garland CF, Gorham ED, Garland FC (2008) The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia 51(8):1391–1398
Tamer G, Arik S, Tamer I, Coksert D (2011) Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid 21:891–896
Kivity S, Agmon-Levin N, Zisappl M, Shapira Y, Nagy EV, Dankó K et al (2011) Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol 8:243–247
Bozkurt NC, Karbek B, Ucan B, Sahin M, Cakal E, Ozbek M et al (2013) The association between severity of vitamin D deficiency and Hashimoto’s thyroiditis. Endocr Pract 19(3):479–484
Effraimidis G, Badenhoop K, Tijssen GPJ, Wiersinga WM (2012) Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol 167:43–48
Goswami R, Marwaha RK, Gupta N, Tandon N, Sreenivas V, Tomar N et al (2009) Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr 102:382–386
Doniach D, Botttazo LB, Russell RCG (1979) Goitrous autoimmune thyroiditis. Clin Endocrinol (Oxf) 8:63–80
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mansournia, N., Mansournia, M.A., Saeedi, S. et al. The association between serum 25OHD levels and hypothyroid Hashimoto’s thyroiditis. J Endocrinol Invest 37, 473–476 (2014). https://doi.org/10.1007/s40618-014-0064-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-014-0064-y